| |
| |
|
| Insider
Information: |
Arroyo Santiago |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
41,750 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,864 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
41,750 |
|
|
| Total
Value |
$3,864 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
SVP, Chief Medical Off... |
2020-10-01 |
0 |
2017-06-20 |
0 |
Premium* |
|
|
Marinus Pharmaceuticals Inc |
MRNS |
Director |
2022-02-04 |
2,750 |
2022-02-04 |
0 |
Premium* |
|
|
Bicycle Therapeutics Ltd |
BCYC |
|
2024-02-06 |
39,000 |
2024-01-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BCYC |
Bicycle Therapeutics Ltd |
CHIEF DEVELOPMENT OFFICER |
• – – |
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
21,660 |
39,000 |
0 |
- |
|
| BCYC |
Bicycle Therapeutics Ltd |
Chief Development Officer |
• – – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
17,340 |
17,340 |
0 |
- |
|
| MRNS |
Marinus Pharmaceuticals I... |
Director |
– • – |
2022-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
2,750 |
2,750 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-10-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(26) |
0 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-08-05 |
4 |
AS |
$32.65 |
$3,069 |
D/D |
(94) |
0 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-08-04 |
4 |
OE |
$12.76 |
$516,591 |
D/D |
32,656 |
34,636 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-08-04 |
4 |
AS |
$32.25 |
$1,113,980 |
D/D |
(34,542) |
94 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-07-29 |
4 |
AS |
$30.00 |
$1,188,540 |
D/D |
(39,618) |
1,886 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-07-29 |
4 |
OE |
$12.76 |
$516,591 |
D/D |
32,656 |
41,504 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-07-28 |
4 |
AS |
$30.00 |
$20,430 |
D/D |
(681) |
8,848 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-07-22 |
4 |
AS |
$32.32 |
$62,668 |
D/D |
(1,939) |
9,529 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-07-21 |
4 |
AS |
$34.62 |
$1,729,858 |
D/D |
(49,967) |
11,468 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-07-21 |
4 |
A |
$12.76 |
$516,591 |
D/D |
32,656 |
61,435 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-07-20 |
4 |
AS |
$33.95 |
$52,996 |
D/D |
(1,561) |
28,779 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-07-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,500 |
30,340 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-07-15 |
4 |
AS |
$35.35 |
$1,815,364 |
D/D |
(51,354) |
26,840 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-07-15 |
4 |
A |
$12.76 |
$516,591 |
D/D |
32,656 |
78,194 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-06-30 |
4 |
AS |
$35.10 |
$239,101 |
D/D |
(6,812) |
45,538 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
52,350 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-06-12 |
4 |
AS |
$30.16 |
$203,761 |
D/D |
(6,756) |
37,350 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
44,106 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-04-20 |
4 |
AS |
$28.96 |
$46,741 |
D/D |
(1,614) |
29,106 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-04-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,500 |
30,720 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-03-06 |
4 |
AS |
$28.97 |
$213,103 |
D/D |
(7,356) |
27,220 |
0 |
% |
|
| MNTA |
Momenta Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
34,576 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
